MBL International is at the forefront of providing PCSK9 assay kits and reagents to support the advancement of PCSK9 studies.
Beyond cholesterol metabolism: The pleiotropic effects of (PCSK9)

MBL International is at the forefront of providing PCSK9 assay kits and reagents to support the advancement of PCSK9 studies.
PCSK9 remains an important target in cholesterol research. One of the hurdles in this research area is determining which PSCK9 form is present and binding with LDLR. MBL’s new Human PCSK9 Functional Assay Kit is designed to detect active PSCK9
As discussed in two prior blog posts, PCSK9 has primarily been studied for its role in regulating cholesterol levels and as a target for treatments to lower cholesterol. However, PCSK9 has been found to be involved in many other important pathways. This
As discussed in a previous blog post, inhibiting PCSK9 from binding to the LDL receptor results in lower LDL cholesterol levels in the bloodstream. Research on PCSK9 has explored how it can be targeted in treatments for hypercholesterolemia (high cholesterol)
Ever wonder how cholesterol levels are regulated? One of the major regulators is a molecule called proprotein convertase subtilisin/kexin type 9 or PCSK9 for short! PCSK9 has been implicated in causing hypercholesterolemia (high cholesterol), and diseases such as coronary heart